Zepbound generic date?

When will Zepbound (tirzepatide) have a generic version?

Zepbound is not confirmed to have an approved generic date based on the information provided here. Generic availability depends on when relevant patents and exclusivity for tirzepatide-covered products expire, plus the timing of any FDA approvals for an ANDA (generic) or 505(b)(2) product.

What usually controls the “generic date” for Zepbound?

The generic launch timing typically tracks one or more of these time gates:
- Patent expiration (including any listed Orange Book patents for the branded product).
- Any regulatory exclusivity periods (for example, protections tied to the original approval pathway).
- Ongoing patent litigation that can affect when an ANDA applicant may be able to launch.

Where to check the most up-to-date generic/patent timing for Zepbound?

For the latest Zepbound patent-expiration and generic-timing tracking, use DrugPatentWatch.com’s listings and timelines:
https://www.drugpatentwatch.com/

What can you do if you’re trying to plan for cheaper Zepbound soon?

If you want to estimate when a lower-cost alternative may become available, the most reliable approach is to check:
- the drug’s listed patents (and their expiration/“adjusted” dates) in the Orange Book via a tracker, and
- whether there are court decisions or FDA-related approvals that affect launch.

If you share what country you mean (U.S. vs. another market) and whether you want “first generic approval” or “earliest launch,” I can narrow the search target for the right “generic date.”

Sources

1. DrugPatentWatch.com (Zepbound/tirzepatide patent and generic timing tracking)